112 related articles for article (PubMed ID: 23001710)
1. Rapid decline in episodic memory in healthy older adults with high amyloid-β.
Lim YY; Pietrzak RH; Ellis KA; Jaeger J; Harrington K; Ashwood T; Szoeke C; Martins RN; Bush AI; Masters CL; Rowe CC; Villemagne VL; Ames D; Darby D; Maruff P
J Alzheimers Dis; 2013; 33(3):675-9. PubMed ID: 23001710
[TBL] [Abstract][Full Text] [Related]
2. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
Ellis KA; Lim YY; Harrington K; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P;
J Alzheimers Dis; 2013; 34(4):861-71. PubMed ID: 23302660
[TBL] [Abstract][Full Text] [Related]
3. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Laws SM; Ames D; Pietrzak RH; Ellis KA; Harrington KD; Bourgeat P; Salvado O; Darby D; Snyder PJ; Bush AI; Martins RN; Masters CL; Rowe CC; Nathan PJ; Maruff P;
Neurobiol Aging; 2013 Nov; 34(11):2457-64. PubMed ID: 23769397
[TBL] [Abstract][Full Text] [Related]
4. Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease?
Lim YY; Ellis KA; Harrington K; Pietrzak RH; Gale J; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P
J Alzheimers Dis; 2013; 33(4):1167-76. PubMed ID: 23160011
[TBL] [Abstract][Full Text] [Related]
5. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
[TBL] [Abstract][Full Text] [Related]
6. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults.
Lim YY; Ellis KA; Pietrzak RH; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
Neurology; 2012 Oct; 79(16):1645-52. PubMed ID: 23071163
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults.
Hollands S; Lim YY; Buckley R; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Lautenschlager N; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P
J Alzheimers Dis; 2015; 43(2):677-86. PubMed ID: 25114076
[TBL] [Abstract][Full Text] [Related]
8. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.
Lim YY; Pietrzak RH; Bourgeat P; Ames D; Ellis KA; Rembach A; Harrington K; Salvado O; Martins RN; Snyder PJ; Masters CL; Rowe CC; Villemagne VL; Maruff P
Arch Clin Neuropsychol; 2015 Feb; 30(1):49-58. PubMed ID: 25467942
[TBL] [Abstract][Full Text] [Related]
9. Aβ and cognitive change: examining the preclinical and prodromal stages of Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ellis KA; Darby D; Ames D; Harrington K; Martins RN; Masters CL; Szoeke C; Savage G; Villemagne VL; Rowe CC;
Alzheimers Dement; 2014 Nov; 10(6):743-751.e1. PubMed ID: 24589436
[TBL] [Abstract][Full Text] [Related]
10. Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden.
Rembach A; Watt AD; Wilson WJ; Villemagne VL; Burnham SC; Ellis KA; Maruff P; Ames D; Rowe CC; Macaulay SL; Bush AI; Martins RN; Masters CL; Doecke JD;
J Alzheimers Dis; 2014; 40(1):95-104. PubMed ID: 24334723
[TBL] [Abstract][Full Text] [Related]
11. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease.
Buckley RF; Maruff P; Ames D; Bourgeat P; Martins RN; Masters CL; Rainey-Smith S; Lautenschlager N; Rowe CC; Savage G; Villemagne VL; Ellis KA;
Alzheimers Dement; 2016 Jul; 12(7):796-804. PubMed ID: 26852195
[TBL] [Abstract][Full Text] [Related]
12. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Pietrzak RH; Ames D; Ellis KA; Harrington K; Snyder PJ; Martins RN; Masters CL; Rowe CC; Maruff P;
Neurobiol Aging; 2015 Mar; 36(3):1239-44. PubMed ID: 25559335
[TBL] [Abstract][Full Text] [Related]
13. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
[TBL] [Abstract][Full Text] [Related]
14. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
[TBL] [Abstract][Full Text] [Related]
15. Aβ amyloid, cognition, and APOE genotype in healthy older adults.
Lim YY; Ellis KA; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
Alzheimers Dement; 2013 Sep; 9(5):538-45. PubMed ID: 23159043
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden.
Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
Neurology; 2017 May; 88(18):1759-1767. PubMed ID: 28381517
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study.
Aschenbrenner AJ; Balota DA; Fagan AM; Duchek JM; Benzinger TL; Morris JC
J Int Neuropsychol Soc; 2015 Sep; 21(8):573-83. PubMed ID: 26416094
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
[TBL] [Abstract][Full Text] [Related]
19. Visual paired associate learning deficits associated with elevated beta-amyloid in cognitively normal older adults.
Baker JE; Pietrzak RH; Laws SM; Ames D; Villemagne VL; Rowe CC; Masters CL; Maruff P; Lim YY
Neuropsychology; 2019 Oct; 33(7):964-974. PubMed ID: 31368758
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.
Thai C; Lim YY; Villemagne VL; Laws SM; Ames D; Ellis KA; Rainey-Smith SR; Martins RN; Masters CL; Rowe CC; Maruff P;
PLoS One; 2015; 10(10):e0139082. PubMed ID: 26430784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
